Suchergebnisse - "Combined Modality Therapy"

PubPharm (23)

1

Locoregional therapies for hepatocellular carcinoma : The current status and future perspectives

enthalten in: United European gastroenterology journal | 2024

von Chen, J. | Jin, Z. | Zhong, B. | +6

2

Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211) : a propensity score matching study

enthalten in: European radiology | 2023

von Jin, Z. | Zhong, B. | Chen, J. | +14

3

Chemotherapy-induced nausea and vomiting

enthalten in: HNO | 2023

von Karthaus, M.

4

Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

enthalten in: Journal for immunotherapy of cancer | 2022

von Kowalczyk, J. | Fabian, K. | Padget, M. | +6

5

Radiation therapy and targeted therapies : Risks and opportunities

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2022

von Nicolas, E. | Lucia, F.

6

Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma

enthalten in: Oral oncology | 2019

von Sher, D. | Yan, J. | Day, A. | +4

7

Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma

enthalten in: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery | 2018

von Li, Z. | Lu, T.

8

Optimizing Breast Cancer Management

Erschienen: Cham, Springer International Publishing, 2018

Cancer Treatment and Research - 173

von Gradishar, W.

9

Programmed death-1 pathway blockade produces a synergistic antitumor effect : combined application in ovarian cancer

enthalten in: Journal of gynecologic oncology | 2017

von Zhu, X. | Lang, J.

10

Adjunction of a MEK inhibitor to Vemurafenib in the treatment of metastatic melanoma results in a 60% reduction of acute kidney injury

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Teuma, C. | Pelletier, S. | Amini-Adl, M. | +6